- Filed
- Jun 17, 2026 10:52 AM ET
- Period of report
- Apr 30, 2026
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Stockholders Equity | 2026 · Apr 30, 2026 | $2.33M |
| Stockholders Equity | Q2 2026 · Apr 30, 2026 | $2.33M |
| Stockholders Equity | Q2 2026 · Jan 31, 2026 | $2.22M |
| Stockholders Equity | Q2 2026 · Oct 31, 2025 | $2.06M |
| Stockholders Equity | Q2 2026 · Apr 30, 2025 | $1.81M |
| Stockholders Equity | Q2 2026 · Jan 31, 2025 | $1.56M |
| Stockholders Equity | Q2 2026 · Oct 31, 2024 | $1.44M |
| Cost Of Revenue | 2026 · Apr 30, 2026 | $662.4K |
| Shares Diluted | Q2 2026 · Apr 30, 2026 | 38.5M sh |
| Shares Diluted restated | Q2 2026 · Apr 30, 2025 | 38.5M sh |
| Shares Outstanding | Q2 2026 · Apr 30, 2026 | 38.5M sh |
| Capex | Q2 2026 · Apr 30, 2026 | $71.6K |
| Capex | Q2 2026 · Apr 30, 2025 | $10.67K |
| Operating Cash Flow | Q2 2026 · Apr 30, 2026 | −$126K |
| Operating Cash Flow | Q2 2026 · Apr 30, 2025 | −$129.46K |
| Cash And Equivalents | Q2 2026 · Apr 30, 2026 | $358.31K |
| Cash And Equivalents | Q2 2026 · Oct 31, 2025 | $605.05K |
| Current Liabilities | Q2 2026 · Apr 30, 2026 | $195.85K |
| Current Liabilities | Q2 2026 · Oct 31, 2025 | $129.54K |
| Total Liabilities | Q2 2026 · Apr 30, 2026 | $208.75K |
| Total Liabilities | Q2 2026 · Oct 31, 2025 | $152.44K |
| Current Assets | Q2 2026 · Apr 30, 2026 | $1.66M |
| Current Assets | Q2 2026 · Oct 31, 2025 | $1.52M |
| Total Assets | Q2 2026 · Apr 30, 2026 | $2.54M |
| Total Assets | Q2 2026 · Oct 31, 2025 | $2.21M |
| Eps Diluted | Q2 2026 · Apr 30, 2026 | $0.01 |
| Eps Diluted | Q2 2026 · Apr 30, 2026 | $0.00 |
| Eps Diluted restated | Q2 2026 · Apr 30, 2025 | $0.00 |
| Eps Diluted | Q2 2026 · Apr 30, 2025 | $0.00 |
| Eps Basic | Q2 2026 · Apr 30, 2026 | $0.01 |
| Eps Basic | Q2 2026 · Apr 30, 2026 | $0.00 |
| Eps Basic restated | Q2 2026 · Apr 30, 2025 | $0.00 |
| Eps Basic | Q2 2026 · Apr 30, 2025 | $0.00 |
| Sga Expense | Q2 2026 · Apr 30, 2026 | $285.13K |
| Sga Expense | Q2 2026 · Apr 30, 2026 | $501.69K |
| Sga Expense restated | Q2 2026 · Apr 30, 2025 | $199.82K |
| Sga Expense | Q2 2026 · Apr 30, 2025 | $471.92K |
| Net Income | Q2 2026 · Apr 30, 2026 | $106.06K |
| Net Income | Q2 2026 · Jan 31, 2026 | $161.64K |
| Net Income | Q2 2026 · Apr 30, 2025 | $204.19K |
| Net Income restated | Q2 2026 · Jan 31, 2025 | $36.2K |
| Operating Income | Q2 2026 · Apr 30, 2026 | $108.7K |
| Operating Income | Q2 2026 · Apr 30, 2026 | $276.78K |
| Operating Income restated | Q2 2026 · Apr 30, 2025 | $200.67K |
| Operating Income restated | Q2 2026 · Apr 30, 2025 | $227.63K |
| Revenue | Q2 2026 · Apr 30, 2026 | $808.67K |
| Revenue | Q2 2026 · Apr 30, 2026 | $1.44M |
| Revenue | Q2 2026 · Apr 30, 2025 | $796.37K |
| Revenue restated | Q2 2026 · Apr 30, 2025 | $1.33M |